市場調査レポート

米国のバイオチップ製品・サービス市場:産業分析・規模・シェア・成長率・動向・予測

Biochip Products and Services Market - (Microarrays, Reagents, Drug Discovery, Life Science Research, IVD Tests) U.S. Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018

発行 Transparency Market Research 商品コード 271058
出版日 ページ情報 英文 65 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=102.12円で換算しております。
Back to Top
米国のバイオチップ製品・サービス市場:産業分析・規模・シェア・成長率・動向・予測 Biochip Products and Services Market - (Microarrays, Reagents, Drug Discovery, Life Science Research, IVD Tests) U.S. Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018
出版日: 2013年05月21日 ページ情報: 英文 65 Pages
概要

当レポートでは、米国のバイオチップ製品・サービス市場について調査分析し、市場の動向、市場影響要因のほか、セグメント別、タイプ別、用途別の市場分析を提供し、競合情勢や主要企業プロファイルなども含めて、概略以下の構成でお届けいたします。

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場の概要

  • 市場の動向
    • 市場促進要因
    • 市場抑制要因
    • 市場の機会
  • Porterのファイブフォース分析
  • 市場の魅力分析:製品タイプ別
  • 市場の規模・動向

第4章 米国のバイオチップ市場:セグメント別

  • 概要
  • 米国のバイオチップサービス市場

第5章 米国のバイオチップ製品市場:タイプ別

  • 概要
  • 米国のマイクロアレイ市場
  • 米国の試薬・その他の消耗品市場
  • 米国のその他のバイオチップ製品市場

第6章 米国のバイオチップ製品・サービス市場:用途別

  • 概要
  • ドラッグデリバリー市場向け
  • 生命科学研究市場向け
  • 体外診断(IVD)検査市場向け
  • その他の応用市場向け

第7章 競合情勢

  • 米国のバイオチップ産業の構成

第8章 企業プロファイル

  • Abbott Laboratories
    • 企業概要
    • 財務概要
    • 事業戦略
    • 製品ポートフォリオ
    • 最近の動向
  • Affymetrix Inc.
    • 企業概要
    • 財務概要
    • 事業戦略
    • 製品ポートフォリオ
    • 最近の動向
  • Agilent Technologies
    • 企業概要
    • 財務概要
    • 事業戦略
    • 製品ポートフォリオ
    • 最近の動向
  • Beckman Coulter, Inc.
    • 企業概要
    • 財務概要
    • 事業戦略
    • 製品ポートフォリオ
    • 最近の動向
  • Illumina Incorporated
    • 企業概要
    • 財務概要
    • 事業戦略
    • 製品ポートフォリオ
    • 最近の動向
  • Life Technologies Corporation
    • 企業概要
    • 財務概要
    • 事業戦略
    • 製品ポートフォリオ
    • 最近の動向
  • GE Healthcare
    • 企業概要
    • 財務概要
    • 事業戦略
    • 製品ポートフォリオ
    • 最近の動向
  • Roche
    • 企業概要
    • 財務概要
    • 事業戦略
    • 製品ポートフォリオ
    • 最近の動向

図表

目次

Biochips are miniaturized laboratories that can perform thousands of biochemical reactions such as polymerase chain reaction (PCR) simultaneously and are used for a variety of purposes ranging from disease diagnosis to detection of bioterrorism agents. This report estimates the U.S. market for biochips in terms of revenue (USD million) for the period 2012 to 2018, considering 2011 as the base year.

The biochip market is segmented into products market and services market. The biochip market by products is sub-segmented into three types, namely, microarrays, reagents and other products including biochip instruments and software. The biochip products and services market by application is sub-segmented into drug discovery, life science research, IVD testing and other applications including disease management, forensic medicines, drug-of-abuse testing and military and defense applications.

The report provides an analysis of market dynamics, which includes drivers, restraints and opportunities for the biochip market in the U.S. It also analyses the internal and external market factors and their effect on the ecosystem of the biochip market, with the help of Porter's five force analysis.

The report includes company profiles of key market players such as Affymetrix, Inc., Life Technologies Corporation, Illumina, Inc. and others. Profiles for all market players have been provided based on parameters such as company overview, financial overview, product portfolio, business strategies and recent developments.

The U.S. biochip market is categorized into the following segments:

  • Biochip Market, by Segments
    • Biochip Products Market
    • Biochip Services Market
  • Biochip Products Market, by Types
    • Microarrays
    • Reagents and Other Consumables
    • Others (Biochip Instruments and Software)
  • Biochip Market, by Applications
    • Drug Delivery
    • Life Science Research
    • In Vitro Diagnostic Testing
    • Others (Disease Management, Forensic Medicine, Defense)

Table of Contents

Chapter 1 - Preface

  • 1.1. Report Description
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

Chapter 2 - Executive Summary

Chapter 3 - Market Overview

  • 3.1. Market Dynamics
    • 3.1.1. Market Drivers
      • 3.1.1.1. Rise in the Application of Genomics and Proteomics Technologies in Cancer Research
      • 3.1.1.2. Growth in Drug Discovery, Personalized Medicine and Life Science Research
      • 3.1.1.3. Impact Analysis of Market Drivers
    • 3.1.2. Market Restraints
      • 3.1.2.1. Low Commercial Acceptability of Biochips due to Their High Cost
      • 3.1.2.2. Availability of Alternative Technologies such as Mass Spectrometry and Polymerase Chain Reaction (PCR)
      • 3.1.2.3. Impact Analysis of Market Restraints
    • 3.1.3. Opportunities
      • 3.1.3.1. New Applications of Biochips
  • 3.2. Porter's Five Force Analysis for U.S. Biochip Market
    • 3.2.1. Bargaining Power of Suppliers
    • 3.2.2. Bargaining Power of Buyers
    • 3.2.3. Threat of New Entrants
    • 3.2.4. Threat of Substitutes
    • 3.2.5. Competitive Rivalry
  • 3.3. Market Attractiveness Analysis of U.S. Biochip Market, by Product Type
  • 3.4. Market Size and Trends
    • 3.4.1. U.S. Biochip Market, 2011 - 2018 (USD Million)

Chapter 4 - U.S. Biochip Market, by Segments

  • 4.1. Overview
  • 4.2. U.S. Biochip Services Market
    • 4.2.1. U.S. Biochip Services Market, 2010 - 2018 (USD Million)

Chapter 5 - U.S. Biochip Products Market, by Type

  • 5.1. Overview
  • 5.2. U.S. Microarrays Market
    • 5.2.1. U.S. Microarrays Market, 2010 - 2018 (USD Million)
  • 5.3. U.S. Reagents and Other Consumables Market
    • 5.3.1. U.S. Reagents and Other Consumables Market, 2010 - 2018 (USD Million)
  • 5.4. U.S. Other Biochip Products (Biochip Instruments and Software) Market
    • 5.4.1. U.S. Other Biochip Products Market, 2010 - 2018 (USD Million)

Chapter 6 - The U.S. Biochip Products and Services Market, by Application

  • 6.1. Overview
  • 6.2. U.S. Biochip Products and Services for Drug Delivery Market
    • 6.2.1. U.S. Biochip Products and Services for Drug Delivery Market
  • 6.3. U.S. Biochip Products and Services for Life Science Research Market
    • 6.3.1. U.S. Biochip Products and Services for Life Science Research Market
  • 6.4. U.S. Biochip Products and Services for In Vitro Diagnostic (IVD) Testing Market
    • 6.4.1. U.S Biochip Products and Services for In Vitro Diagnostic Testing Market, 2010 - 2018 (USD Million)
  • 6.5. U.S. Biochip Products and Services for Other Applications (Disease Management, Forensic Medicine, Defense Application) Market
    • 6.5.1. The U.S. Biochip Products and Services for Other Applications Market, 2010 - 2018 (USD Million)

Chapter 7 - Competitive Landscape

  • 7.1 Biochip Industry Composition in U.S.

Chapter 8 - Company Profiles

  • 8.1. Abbott Laboratories
    • 8.1.1. Company Overview
    • 8.1.2. Financial Overview
    • 8.1.3. Business Strategy
    • 8.1.4. Product Portfolio
    • 8.1.5. Recent Developments
  • 8.2. Affymetrix Inc.
    • 8.2.1. Company Overview
    • 8.2.2. Financial Overview
    • 8.2.3. Business Strategy
    • 8.2.4. Product Portfolio
    • 8.2.5. Recent Developments
  • 8.3. Agilent Technologies
    • 8.3.1. Company Overview
    • 8.3.2. Financial Overview
    • 8.3.3. Business Strategy
    • 8.3.4. Product Portfolio
    • 8.3.5. Recent Developments
  • 8.4. Beckman Coulter, Inc.
    • 8.4.1. Company Overview
    • 8.4.2. Financial Overview
    • 8.4.3. Business Strategies
    • 8.4.4. Product Portfolio
    • 8.4.5. Recent Developments
  • 8.5. Illumina Incorporated
    • 8.5.1. Company Overview
    • 8.5.2. Financial Overview
    • 8.5.3. Business Strategies
    • 8.5.4. Product Portfolio
    • 8.5.5. Recent Developments
  • 8.6. Life Technologies Corporation
    • 8.6.1. Company Overview
    • 8.6.2. Financial Overview
    • 8.6.3. Business Strategies
    • 8.6.4. Product Portfolio
    • 8.6.5. Recent Developments
  • 8.7. GE Healthcare
    • 8.7.1. Company Overview
    • 8.7.2. Financial Overview
    • 8.7.3. Business Strategy
    • 8.7.4. Product Portfolio
    • 8.7.5. Recent Developments
  • 8.8. Roche
    • 8.8.1. Company Overview
    • 8.8.2. Financial Overview
    • 8.8.3. Business Strategy
    • 8.8.4. Product Portfolio
    • 8.8.5. Recent Developments

List of Figures

  • FIG. 1: Market Segmentation: U.S. Biochip Market
  • FIG. 2: U.S. Biochip Market, by Product Type, 2011 (USD Million)
  • FIG. 3: Porter's Five Force Analysis for U.S. Biochip Market
  • FIG. 4: Market Attractiveness Analysis of the U.S. Biochip Market, by Product Type
  • FIG. 5: U.S. Biochip Market, 2010 - 2018 (USD Million)
  • FIG. 6: Comparative Analysis: U.S. Biochip Market, by Segments, 2011 & 2018 (Value %)
  • FIG. 7: U.S. Biochip Services Market, 2010 - 2018 (USD Million)
  • FIG. 8: Comparative Analysis: U.S. Biochip Products Market, by Type, 2011 & 2018 (Value %)
  • FIG. 9: U.S. Microarrays Market, 2010 - 2018 (USD Million)
  • FIG. 10: U.S. Reagents and Other Consumables Market, 2010 - 2018 (USD Million)
  • FIG. 11: U.S. Other Biochip Products Market, 2010 - 2018 (USD Million)
  • FIG. 12: Comparative Analysis: U.S. Biochip Products and Services Market, by Application, 2011 & 2018 (Value %)
  • FIG. 13: U.S. Biochip Products and Services for Drug Delivery Market, 2010 - 2018 (USD Million)
  • FIG. 14: U.S. Biochip Products and Services for Life Science Research Market, 2010 - 2018 (USD Million)
  • FIG. 15: U.S. Biochip Products and Services for In Vitro Diagnostic Testing Market, 2010 - 2018 (USD Million)
  • FIG. 16: U.S. Biochip Products and Services for Other Applications Market, 2010 - 2018 (USD Million)
  • FIG. 17: Annual Revenues: Abbott Laboratories, 2010 - 2011 (USD Million)
  • FIG. 18: Annual Revenues: Affymetrix Incorporated, 2010 - 2011 (USD Million)
  • FIG. 19: Annual Revenues: Agilent Technologies, 2010 - 2011 (USD Million)
  • FIG. 20: Annual Revenues: Illumina Incorporated, 2010 - 2011 (USD Million)
  • FIG. 21: Annual Revenues: Life Technologies Corporation, 2010 - 2011 (USD Million)
  • FIG. 22: Annual Revenues: GE Healthcare, 2010 - 2011 (USD Million)
  • FIG. 23: Annual Revenues: Roche, 2010 - 2011 (USD Million)

List of Tables

  • TABLE 1: Market Snapshot: U.S. Biochip Market
  • TABLE 2: Impact Analysis Of Market Drivers
  • TABLE 3: Impact Analysis Of Market Restraints
Back to Top